- Home
- VEEE vs NLSP Comparison
VEEE vs NLSP Comparison
Compare VEEE & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- NLSP
- Stock Information
- Founded
- VEEE 1994
- NLSP 2015
- Country
- VEEE United States
- NLSP Switzerland
- Employees
- VEEE N/A
- NLSP N/A
- Industry
- VEEE Marine Transportation
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- VEEE Industrials
- NLSP Health Care
- Exchange
- VEEE Nasdaq
- NLSP Nasdaq
- Market Cap
- VEEE 4.7M
- NLSP 5.2M
- IPO Year
- VEEE 2021
- NLSP 2021
- Fundamental
- Price
- VEEE $0.34
- NLSP $2.00
- Analyst Decision
- VEEE
- NLSP
- Analyst Count
- VEEE 0
- NLSP 0
- Target Price
- VEEE N/A
- NLSP N/A
- AVG Volume (30 Days)
- VEEE 55.5K
- NLSP 440.1K
- Earning Date
- VEEE 11-14-2024
- NLSP 12-31-2024
- Dividend Yield
- VEEE N/A
- NLSP N/A
- EPS Growth
- VEEE N/A
- NLSP N/A
- EPS
- VEEE N/A
- NLSP N/A
- Revenue
- VEEE $20,949,492.00
- NLSP N/A
- Revenue This Year
- VEEE $76.99
- NLSP N/A
- Revenue Next Year
- VEEE N/A
- NLSP N/A
- P/E Ratio
- VEEE N/A
- NLSP N/A
- Revenue Growth
- VEEE N/A
- NLSP N/A
- 52 Week Low
- VEEE $0.33
- NLSP $1.75
- 52 Week High
- VEEE $1.64
- NLSP $24.32
- Technical
- Relative Strength Index (RSI)
- VEEE 33.96
- NLSP 22.65
- Support Level
- VEEE $0.35
- NLSP $1.75
- Resistance Level
- VEEE $0.50
- NLSP $2.13
- Average True Range (ATR)
- VEEE 0.05
- NLSP 0.29
- MACD
- VEEE -0.00
- NLSP -0.03
- Stochastic Oscillator
- VEEE 6.67
- NLSP 4.23
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.